Le Lézard
Classified in: Science and technology
Subject: Personnel

Simulmedia Appoints Ken Rona as Chief Scientist


Simulmedia, a trailblazer in data-driven advertising solutions for streaming and linear TV, is delighted to announce the appointment of Ken Rona as the company's new Chief Scientist. "We are thrilled to welcome Ken Rona to the Simulmedia family as our Chief Scientist," said Simulmedia Founder and Executive Chairman Dave Morgan, to whom Dr. Rona will report. "With the rapid growth of Connected TV advertising and Ken's extensive experience in streaming and linear video and programmatic advertising, we believe he is the perfect fit to help us drive innovation and continue to provide cutting-edge solutions to our clients."

Dr. Rona has spent most of the last 20 years helping companies improve how they buy and sell digital media products by applying data, science, and software. He was responsible for building IXI's digital products, leading data strategy and campaign analytics at [x+1], driving digital innovation at Turner Broadcasting, and was a founder of Chalice Custom Algorithms. He is an advisor to startup studio Montauk Labs and The 98, an early-stage venture firm. He has his Ph.D. in behavioral economics from Duke University and is a respected and award-winning expert in optimizing the programmatic media supply chain.

"I was honestly humbled when Dave Morgan asked me to be Simulmedia's Chief Scientist. I have been tracking the company since its inception and could not be more thrilled to help them continue their push into leveraging their incredible dataset to optimize linear and CTV media buying," said Dr. Rona. "Over the past 15 years, Simulmedia has pioneered data-driven buying of Linear TV advertising through its TV+ platform, optimizing billions of dollars of ad spend across major TV channels such as Warner Bros Discovery, NBCU, Disney, and Paramount. In recent years, Simulmedia expanded TV+ to fully integrate ad-supported Connected TV channels, including Hulu, Peacock, MAX, Disney+, and Roku.

eMarketer, an Insider Intelligence Company, projects that combined Linear TV and Connected TV ad spend in the US will grow significantly. Simulmedia's TV+ platform uniquely operates across CTV and Linear, offering fully integrated planning, activation, and optimization capabilities across programmers, channels, distributors, and devices.

About Simulmedia:

Simulmedia is a New York-based technology company specializing in data-driven advertising solutions for advertisers and agencies. Founded in 2008, Simulmedia's Performance TV? products, powered by its patented, AI-driven TV+? analytics and activation platform, deliver high-performance targeted video ad campaigns across all streaming and linear TV channels for more than 100 top brands. Independent studies consistently show that Simulmedia campaigns deliver 30-100% higher ROI than conventionally planned and targeted campaigns, making Simulmedia the only company to guarantee campaign performance, whether the goal is reach, custom targeting, or ROI.


These press releases may also interest you

at 04:09
China and Kazakhstan have always supported each other and have always been partners in times of challenges, Chinese President Xi Jinping said in a signed article in the Kazakhstanskaya Pravda newspaper and Kazinform International News Agency on...

at 04:05
H.I.G. Capital ("H.I.G."), a leading global alternative investment firm with $64 billion of capital under management, is pleased to announce that an affiliate has signed a definitive agreement to acquire CGH Group S.A. ("CGH" or the "Company"), a...

at 03:55
The International Nut and Dried Fruit Council (INC), conducted an extensive study on Latin America's Gen Z dietary...

at 03:44
Truecaller, the leading global platform for verifying contacts and blocking unwanted communication, is publishing its interim report for January-June on Friday 19 July 2024 at 07.30 CET.  Alan Mamedi, CEO and Odd Bolin, CFO presents the report and...

at 03:20
Calliditas Therapeutics AB (STO: CALTX) ("Calliditas") today announces that its partner Viatris Pharmaceutical Japan G.K. ("Viatris") has initiated a phase III clinical trial in Japan with Nefecon, named VR-205 in the Japanese market, in Japanese...

at 03:09
China and Kazakhstan have always supported each other and have always been partners in times of challenges, Chinese President Xi Jinping said in a signed article in the Kazakhstanskaya Pravda newspaper and Kazinform International News Agency on...



News published on and distributed by: